4
edits
m (→Adult T-cell leukemia/lymphoma: fix ref.) |
|||
| (74 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
[[Image:Lymphoma macro.jpg | thumb | 200px | right | Lymphoma at [[cut-up]]. (WC/Emmanuelm)]] | |||
'''Lymphoma''' is almost a specialty for itself. It can be subclassified a number of ways. | '''Lymphoma''' is almost a specialty for itself. It can be subclassified a number of ways. | ||
| Line 4: | Line 5: | ||
A general introduction to haematopathology is in the ''[[haematopathology]]'' article. | A general introduction to haematopathology is in the ''[[haematopathology]]'' article. | ||
==General== | |||
The presentations are variable and similar to that of other malignancies. They may include: | |||
*Mass effect. | |||
*Weight loss. | |||
*Fever. | |||
*Night sweats. | |||
*Infection. | |||
*Incidental: | |||
**Routine blood work for something unrelated. | |||
**Life insurance work-up. | |||
===B symptoms=== | |||
*May be seen in [[Hodgkin lymphoma]] and non-Hodgkin lymphoma. | |||
*Presence correlates with higher stage. | |||
*Predictor of poor prognosis independent of stage. | |||
All of 'em are required to call "B symptoms"<ref name=pmid5121694>{{Cite journal | last1 = Carbone | first1 = PP. | last2 = Kaplan | first2 = HS. | last3 = Musshoff | first3 = K. | last4 = Smithers | first4 = DW. | last5 = Tubiana | first5 = M. | title = Report of the Committee on Hodgkin's Disease Staging Classification. | journal = Cancer Res | volume = 31 | issue = 11 | pages = 1860-1 | month = Nov | year = 1971 | doi = | PMID = 5121694 | URL = http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=5121694 }}</ref> - mnemonic ''These '''B'''othersome features cause '''W'''ednesday '''N'''ight '''F'''ever'':<ref>URL: [http://www.internalizemedicine.com/2011/12/bury-buzzword-b-symptoms.html http://www.internalizemedicine.com/2011/12/bury-buzzword-b-symptoms.html]. Accessed on: 28 March 2012.</ref> | |||
*Weight loss - >10% in 6 months. | |||
*Night sweats. | |||
*Fever - 38 degree C that is unexplained. | |||
Note: | |||
*''A symptoms'' do '''not''' exist. The term comes from the staging system. In the "A" of the staging system the above symptoms are '''a'''bsent. | |||
==Lymphoma classification== | ==Lymphoma classification== | ||
Lymphomas can be divided into: | Lymphomas can be divided into: | ||
*Hodgkin's lymphoma. | *[[Hodgkin's lymphoma]]. | ||
*Non-Hodgkin's lymphoma (NHL). | *Non-Hodgkin's lymphoma (NHL). | ||
| Line 15: | Line 40: | ||
Two most common NHLs: | Two most common NHLs: | ||
*Follicular lymphoma (FL). | *[[Follicular lymphoma]] (FL). | ||
*Diffuse large B-cell lymphoma (DLBCL). | *[[Diffuse large B-cell lymphoma]] (DLBCL). | ||
===Leukemia as a med student=== | ===Leukemia as a med student=== | ||
*Acute lymphoid leukemia (ALL) - predominantly in '''smALL''' people, i.e. children. | *Acute lymphoid leukemia (ALL) - predominantly in '''smALL''' people, i.e. children. | ||
*Acute myeloid leukemia (AML). | *[[Acute myeloid leukemia]] (AML). | ||
*Chronic myeloid leukemia (CML). | *[[Chronic myeloid leukemia]] (CML). | ||
*Chronic | *[[Chronic lymphocytic leukemia]] (CLL) - relatively good prognosis. | ||
===Histologic classification=== | ===Histologic classification=== | ||
| Line 59: | Line 84: | ||
|} | |} | ||
===Histologic terms=== | ====Histologic terms==== | ||
*Lymphomas = cells look discohesive, may be difficult to differentiate from poor differentiated carcinoma. | *Lymphomas = cells look discohesive, may be difficult to differentiate from poor differentiated carcinoma. | ||
*Auer rods = | *[[Auer rods]] = [[acute myeloid leukemia]]. | ||
**Granular cytoplasmic rod (0.5-1 x4-6 micrometres). | **Granular cytoplasmic rod (0.5-1 x4-6 micrometres). | ||
**Not pathognomonic. | |||
*Reed-Sternberg cells = [[Hodgkin's lymphoma]]. | *Reed-Sternberg cells = [[Hodgkin's lymphoma]]. | ||
**Large cell - very large nucleus. | **Large cell - very large nucleus. | ||
| Line 79: | Line 105: | ||
Others: | Others: | ||
*AE1/AE3 -- to r/o carcinoma. | *[[AE1/AE3]] -ve -- to r/o carcinoma. | ||
====T cell markers==== | ====T cell markers==== | ||
| Line 109: | Line 135: | ||
*Lambda. | *Lambda. | ||
*CD56<ref>URL: [http://www.ncbi.nlm.nih.gov/omim/116930 http://www.ncbi.nlm.nih.gov/omim/116930]. Accessed on: 31 August 2010.</ref> -- also +ve in NK/T cell lymphomas. | *CD56<ref>URL: [http://www.ncbi.nlm.nih.gov/omim/116930 http://www.ncbi.nlm.nih.gov/omim/116930]. Accessed on: 31 August 2010.</ref> -- also +ve in NK/T cell lymphomas. | ||
*CD57 -- +ve in T-cell large granular lymphocytic leukemia.<ref>URL: [http://www.nature.com/bmt/journal/v33/n1/full/1704298a.html http://www.nature.com/bmt/journal/v33/n1/full/1704298a.html]. Accessed on: 31 August 2010.</ref>. | *CD57 -- +ve in [[T-cell large granular lymphocytic leukemia]].<ref>URL: [http://www.nature.com/bmt/journal/v33/n1/full/1704298a.html http://www.nature.com/bmt/journal/v33/n1/full/1704298a.html]. Accessed on: 31 August 2010.</ref>. | ||
*CD138. | *CD138. | ||
====Follicular dendritic cells==== | ====Follicular dendritic cells==== | ||
*CD23 -- follicular dendritic cells. | *CD23 -- follicular dendritic cells. | ||
*CD21 -- follicular dendritic cells. | *CD21 -- follicular dendritic cells, considered more sensitive than CD23.<ref name=pmid16280657>{{Cite journal | last1 = Troxell | first1 = ML. | last2 = Schwartz | first2 = EJ. | last3 = van de Rijn | first3 = M. | last4 = Ross | first4 = DT. | last5 = Warnke | first5 = RA. | last6 = Higgins | first6 = JP. | last7 = Natkunam | first7 = Y. | title = Follicular dendritic cell immunohistochemical markers in angioimmunoblastic T-cell lymphoma. | journal = Appl Immunohistochem Mol Morphol | volume = 13 | issue = 4 | pages = 297-303 | month = Dec | year = 2005 | doi = | PMID = 16280657 }}</ref> | ||
====Hodgkin's lymphoma==== | ====Hodgkin's lymphoma==== | ||
| Line 139: | Line 165: | ||
*TdT. | *TdT. | ||
*CD34. | *CD34. | ||
===Molecular pathology=== | |||
{{Main|Molecular pathology}} | |||
{{Main|Molecular pathology tests}} | |||
*T cell clonality study. | |||
*B cell clonality study. | |||
====Chromosomal translocations==== | |||
{{Main|Chromosomal_translocations#Lymphoma}} | |||
==Hodgkin's lymphoma== | ==Hodgkin's lymphoma== | ||
| Line 222: | Line 257: | ||
==Intravascular lymphoma== | ==Intravascular lymphoma== | ||
*[[AKA]] ''angiotropic lymphoma'', ''intravascular malignant lymphomatosis'', ''malignant angioendotheliomatosis'' | |||
*Rare. | *Rare. | ||
*Usually B-cell lineage (see | *Usually B-cell lineage (see ''[[intravascular large B-cell lymphoma]]''). | ||
**May be T-cell lineage.<ref name=pmid20337769>{{cite journal |author=Wang L, Li C, Gao T |title=Cutaneous intravascular anaplastic large cell lymphoma |journal=J Cutan Pathol |volume= |issue= |pages= |year=2010 |month=March |pmid=20337769 |doi=10.1111/j.1600-0560.2010.01538.x |url=}}</ref> | **May be T-cell lineage.<ref name=pmid20337769>{{cite journal |author=Wang L, Li C, Gao T |title=Cutaneous intravascular anaplastic large cell lymphoma |journal=J Cutan Pathol |volume= |issue= |pages= |year=2010 |month=March |pmid=20337769 |doi=10.1111/j.1600-0560.2010.01538.x |url=}}</ref> | ||
==Burkitt's lymphoma== | ==Burkitt's lymphoma== | ||
| Line 308: | Line 312: | ||
**Images: [http://en.wikipedia.org/wiki/File:Auer_rods.PNG Auer rods (WP)], [http://www.healthsystem.virginia.edu/internet/hematology/HessImages/Acute-myelogenous-leukemia-M4-100x-Auer-rods-website-arrow.jpg Auer rods (virginia.edu)]. | **Images: [http://en.wikipedia.org/wiki/File:Auer_rods.PNG Auer rods (WP)], [http://www.healthsystem.virginia.edu/internet/hematology/HessImages/Acute-myelogenous-leukemia-M4-100x-Auer-rods-website-arrow.jpg Auer rods (virginia.edu)]. | ||
==Enteropathy-associated T cell lymphoma | ==Enteropathy-associated T-cell lymphoma== | ||
*Abbreviated ''EATL''. | *Abbreviated ''EATL''. | ||
*[[AKA]] ''enteropathy-type T cell lymphoma'' (ETTL). | *[[AKA]] ''enteropathy-type T-cell lymphoma'' (ETTL). | ||
{{Main|Enteropathy-associated T-cell lymphoma}} | |||
==Angioimmunoblastic T-cell lymphoma== | ==Angioimmunoblastic T-cell lymphoma== | ||
*Abbreviated ''AITL''. | |||
===General=== | |||
*Rare. | |||
**Common among T-cell lymphomas. | |||
*Middle age ''or'' elderly. | |||
===Microscopic=== | ===Microscopic=== | ||
Features: | Features: | ||
*Clear cytoplasm. | *Intermediate size cells with: | ||
**+/-[[Vesicular nuclei]]. | |||
**Clear, moderate cytoplasm. | |||
*"Empty" sinus; subcapsular sinuses "open". | *"Empty" sinus; subcapsular sinuses "open". | ||
Images: | |||
*[http://www.ijpmonline.org/viewimage.asp?img=IndianJPatholMicrobiol_2010_53_4_640_72010_f4.jpg AITL (ijpmonline.org)].<ref name=pmid21045384>{{Cite journal | last1 = Bal | first1 = M. | last2 = Gujral | first2 = S. | last3 = Gandhi | first3 = J. | last4 = Shet | first4 = T. | last5 = Epari | first5 = S. | last6 = Subramanian | first6 = PG. | title = Angioimmunoblastic T-Cell lymphoma: a critical analysis of clinical, morphologic and immunophenotypic features. | journal = Indian J Pathol Microbiol | volume = 53 | issue = 4 | pages = 640-5 | month = | year = | doi = 10.4103/0377-4929.72010 | PMID = 21045384 | URL = http://www.ijpmonline.org/text.asp?2010/53/4/640/72010 }}</ref> | |||
*[http://path.upmc.edu/cases/case650.html AITL - several images (upmc.edu)] | |||
===IHC=== | ===IHC=== | ||
Features - positives:<ref name=pmid21045384/> | |||
*CD3 +ve. | |||
*CD5 +ve. | |||
*CD43 +ve. | |||
Others: | |||
*CD4 +ve and CD8 +ve with CD4>CD8. | |||
*CD20 +ve/-ve! | |||
*CD10 +ve/-ve! | |||
*CD21 +ve -- prominent FDC meshworks;<ref>URL: [http://path.upmc.edu/cases/case650/dx.html http://path.upmc.edu/cases/case650/dx.html]. Accessed on: 27 January 2012.</ref> tumour cell not +ve. | |||
Negatives: | |||
*CD30 -ve.<ref name=pmid21045384/> | |||
*CD15 -ve.<ref name=pmid21045384/> | |||
*CD7 -ve. | *CD7 -ve. | ||
*TIA-1 -ve. | *TIA-1 -ve. | ||
| Line 336: | Line 356: | ||
*Abbreviated ''PMBL''. | *Abbreviated ''PMBL''. | ||
*[[AKA]] ''primary mediastinal large B-cell lymphoma''. | *[[AKA]] ''primary mediastinal large B-cell lymphoma''. | ||
{{Main|Primary mediastinal B-cell lymphoma}} | |||
==Anaplastic large cell lymphoma== | ==Anaplastic large cell lymphoma== | ||
*Abbreviated ''ALCL''. | *Abbreviated ''ALCL''. | ||
{{Main|Anaplastic large cell lymphoma}} | |||
==Cutaneous T cell lymphoma== | ==Cutaneous T cell lymphoma== | ||
| Line 401: | Line 378: | ||
*[http://www.flickr.com/photos/32549645@N02/3040759595/ Sézary cell (flickr.com)]. | *[http://www.flickr.com/photos/32549645@N02/3040759595/ Sézary cell (flickr.com)]. | ||
*[http://www.wadsworth.org/chemheme/heme/glass/cytopix/slide015_sezary2.jpg Sézary cell (wadsworth.org)]. | *[http://www.wadsworth.org/chemheme/heme/glass/cytopix/slide015_sezary2.jpg Sézary cell (wadsworth.org)]. | ||
==T-cell large granular lymphocytic leukemia== | |||
===General=== | |||
*May be seen in the context of [[Felty syndrome]]. | |||
===Microscopic=== | |||
Features: | |||
*Large cell lymphoma. | |||
Images: | |||
*[http://path.upmc.edu/cases/case695.html T-cell large granular lymphocytic leukemia (upmc.edu)]. | |||
===IHC=== | |||
*CD57 +ve -- '''important'''. | |||
*CD3 +ve. | |||
*CD5 +ve. | |||
*CD45 +ve. | |||
==Lymphoplasmacytic lymphoma== | ==Lymphoplasmacytic lymphoma== | ||
:''Waldenström macroglobulinemia'' redirects here. | |||
===General=== | ===General=== | ||
Features:<ref name=Ref_PCPBoD8_325>{{Ref PCPBoD8|325}}</ref> | Features:<ref name=Ref_PCPBoD8_325>{{Ref PCPBoD8|325}}</ref> | ||
| Line 409: | Line 403: | ||
*Secretes monoclonal IgM. | *Secretes monoclonal IgM. | ||
Clinical:<ref name=Ref_PCPBoD8_325>{{Ref PCPBoD8|325}}</ref> | Note: | ||
*Symptoms of blood hyperviscosity | *''Waldenström macroglobulinemia'' is a type of lymphoplasmacytic lymphoma<ref name=pmid22507796>{{Cite journal | last1 = Gertz | first1 = MA. | title = Waldenström macroglobulinemia. | journal = Hematology | volume = 17 Suppl 1 | issue = | pages = 112-6 | month = Apr | year = 2012 | doi = 10.1179/102453312X13336169156212 | PMID = 22507796 }}</ref> - it is characterized by: | ||
**''Hyperviscosity syndrome''. | |||
**Bony destruction (seen in [[multiple myeloma]]) is absent.<ref name=Ref_PCPBoD8_325>{{Ref PCPBoD8|325}}</ref> | |||
**Over 90% of patients have the MYD88 L265P somatic mutation.<ref name=pmid=22931316>{{cite journal |vauthors=Treon SP, Xu L, Yang G, Zhou Y, Liu X, Cao Y, Sheehy P, Manning RJ, Patterson CJ, Tripsas C, Arcaini L, Pinkus GS, Rodig SJ, Sohani AR, Harris NL, Laramie JM, Skifter DA, Lincoln SE, Hunter ZR |title=MYD88 L265P somatic mutation in Waldenström's macroglobulinemia |journal=N Engl J Med |volume=367 |issue=9 |pages=826–33 |date=August 2012 |pmid=22931316 |doi=10.1056/NEJMoa1200710 |url=}}</ref> | |||
====Clinical==== | |||
Features:<ref name=Ref_PCPBoD8_325>{{Ref PCPBoD8|325}}</ref> | |||
*Symptoms of blood hyperviscosity - these include: | |||
**Visual impairment. | |||
**Neurologic impairment. | |||
**Bleeding. | |||
**[[Cryoglobulinemia]] - may have ''Raynaud phenomenon''. | |||
*Hemolysis. | *Hemolysis. | ||
*Bence-Jones proteinuria - seen in over half of patients.<ref name=pmid11797112>{{Cite journal | last1 = Kyrtsonis | first1 = MC. | last2 = Vassilakopoulos | first2 = TP. | last3 = Angelopoulou | first3 = MK. | last4 = Siakantaris | first4 = P. | last5 = Kontopidou | first5 = FN. | last6 = Dimopoulou | first6 = MN. | last7 = Boussiotis | first7 = V. | last8 = Gribabis | first8 = A. | last9 = Konstantopoulos | first9 = K. | title = Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients. Experience from a single hematology unit. | journal = Ann Hematol | volume = 80 | issue = 12 | pages = 722-7 | month = Dec | year = 2001 | doi = 10.1007/s00277-001-0385-8 | PMID = 11797112 }}</ref> | |||
Treatment: | |||
*Watchful waiting or chemotherapy. | |||
*Hyperviscosity syndrome: plasmapheresis. | |||
===Microscopic=== | ===Microscopic=== | ||
| Line 417: | Line 427: | ||
*Plasmacytoid lymphocytes. | *Plasmacytoid lymphocytes. | ||
*Mixed inflammatory infiltrate with [[mast cell]]s, [[plasma cell]]s, lymphocytes. | *Mixed inflammatory infiltrate with [[mast cell]]s, [[plasma cell]]s, lymphocytes. | ||
DDx: | |||
*[[Plasma cell neoplasm]]. | |||
===IHC=== | |||
Features:<ref name=pmid20654153>{{Cite journal | last1 = Liu | first1 = EB. | last2 = Zhang | first2 = PH. | last3 = Li | first3 = ZQ. | last4 = Sun | first4 = Q. | last5 = Yang | first5 = QY. | last6 = Fang | first6 = LH. | last7 = Sun | first7 = FJ. | last8 = Qiu | first8 = LG. | title = [Clinicopathologic features of lymphoplasmacytic lymphoma]. | journal = Zhonghua Bing Li Xue Za Zhi | volume = 39 | issue = 5 | pages = 308-12 | month = May | year = 2010 | doi = | PMID = 20654153 }}</ref> | |||
*PAX5 +ve. | |||
*CD20 +ve. | |||
*CD38 +ve. | |||
*CD138 +ve. | |||
Others:<ref name=pmid20654153/> | |||
*CD5 -ve. | |||
*CD10 -ve. | |||
*CD23 -ve. | |||
*CyclinD1 -ve. | |||
*CD3 -ve. | |||
*CD7 -ve. | |||
==Adult T-cell leukemia/lymphoma== | ==Adult T-cell leukemia/lymphoma== | ||
| Line 425: | Line 453: | ||
===Microscopic=== | ===Microscopic=== | ||
Features:<ref name=Ref_PCPBoD8_328>{{Ref PCPBoD8|328}}</ref> | Features:<ref name=Ref_PCPBoD8_328>{{Ref PCPBoD8|328}}</ref> | ||
*Cloverleaf nuclei | *Cloverleaf nuclei. | ||
**Nuclei with multiple lobulations. | |||
Image: | |||
*[http://www.pathpedia.com/education/eatlas/histopathology/blood_cells/adult_t-cell_leukemia_htlv1-positive_acute_form/adult-t-cell-leukemia-htlv1-%5B2-bl095-2%5D.jpeg?Width=600&Height=450&Format=4 Cloverleaf nucleus (pathpedia.com)].<ref>URL: [http://www.pathpedia.com/education/eatlas/histopathology/blood_cells/adult_t-cell_leukemia_htlv1-positive_acute_form.aspx http://www.pathpedia.com/education/eatlas/histopathology/blood_cells/adult_t-cell_leukemia_htlv1-positive_acute_form.aspx]. Accessed on: 7 February 2012.</ref> | |||
===IHC=== | |||
Features:<ref name=pmid19165640>{{Cite journal | last1 = Bittencourt | first1 = AL. | last2 = Barbosa | first2 = HS. | last3 = Vieira | first3 = MD. | last4 = Farré | first4 = L. | title = Adult T-cell leukemia/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases. | journal = Acta Oncol | volume = 48 | issue = 4 | pages = 598-604 | month = | year = 2009 | doi = 10.1080/02841860802657235 | PMID = 19165640 |URL = http://informahealthcare.com/doi/pdf/10.1080/02841860802657235 }}</ref> | |||
*CD3 +ve. | |||
*CD5 +ve. | |||
*CD25 +ve. | |||
*CD45 +ve. | |||
*HTLV-1 +ve. | |||
Others:<ref name=pmid19165640/> | |||
*CD7 -ve. | |||
*CD20 -ve. | |||
*CD79a -ve. | |||
==Hepatosplenic T-cell lymphoma== | |||
{{Main|Hepatosplenic T-cell lymphoma}} | |||
==Extranodal NK/T-cell lymphoma, nasal type== | |||
*Abbreviated as ''ENKL'' or ''ENKTCL''. | |||
*[[AKA]] ''extranodal natural kill lymphoma'' | |||
*[[AKA]] ''angiocentric lymphoma''. | |||
{{Main|Extranodal NK/T-cell lymphoma, nasal type}} | |||
==Table of lymphoma== | ==Table of lymphoma== | ||
| Line 504: | Line 558: | ||
| lymph node usually, germinal center | | lymph node usually, germinal center | ||
| sheets of large discohesive cells; if only nodular = follicular lymphoma | | sheets of large discohesive cells; if only nodular = follicular lymphoma | ||
| | | MIB1 >40% | ||
| none / like follicular lymphoma t(14,18) / c-MYC (like Burkitt lymphoma) | | none / like follicular lymphoma t(14,18) / c-MYC (like Burkitt lymphoma) | ||
| poor prognosis | | poor prognosis | ||
| Line 553: | Line 607: | ||
! DDx | ! DDx | ||
|- | |- | ||
| Angioimmunoblastic lymphoma | | [[Angioimmunoblastic lymphoma]] | ||
| size of cells ? | | size of cells ? | ||
| site ? | | site ? | ||
| Line 583: | Line 637: | ||
| DDx ? | | DDx ? | ||
|- | |- | ||
| [[ | | [[Adult T-cell leukemia/lymphoma|Adult T-cell lymphoma / leukemia]] | ||
| size of cells ? | | size of cells ? | ||
| site ? | | site ? | ||
| Line 613: | Line 667: | ||
| carcinoma | | carcinoma | ||
|- | |- | ||
| Extranodal NK / T cell lymphoma nasal type | | [[Extranodal NK/T-cell lymphoma, nasal type|Extranodal NK/T cell lymphoma nasal type]] | ||
| | | large ??? | ||
| | | nasal ??? | ||
| histomorphology ? | | histomorphology ? | ||
| EBER+, CD16+, CD56+, CD57-, TIA-1+, Granzyme B+ | | EBER+, CD16+, CD56+, CD57-, TIA-1+, Granzyme B+ | ||
| translocations ? | | translocations ? | ||
| | | common in East Asia | ||
| | | uncommon | ||
| DDx ? | | DDx ? | ||
|- | |- | ||
edits